Anti-EGFR plus chemotherapy in unselected advanced oesophageal squamous cell carcinoma: less POWERful than expected

Ann Oncol. 2020 Feb;31(2):161-162. doi: 10.1016/j.annonc.2019.11.009.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cisplatin
  • ErbB Receptors
  • Esophageal Neoplasms*
  • Esophageal Squamous Cell Carcinoma*
  • Fluorouracil
  • Humans
  • Panitumumab
  • Prospective Studies

Substances

  • Panitumumab
  • EGFR protein, human
  • ErbB Receptors
  • Cisplatin
  • Fluorouracil